Screener
Axsome Therapeutics AXSM Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $8.65B.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
FAQ
- What is Axsome Therapeutics's market capitalization?
- Axsome Therapeutics (AXSM) reported market capitalization of $8.65B in Q1 2026.
- How has Axsome Therapeutics's market capitalization changed year-over-year?
- Axsome Therapeutics's market capitalization increased by 52.0% year-over-year, from $5.69B to $8.65B.
- What is the long-term trend for Axsome Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Axsome Therapeutics's market capitalization has grown at a 24.7% compound annual growth rate (CAGR), from $3.05B to $9.21B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Axsome Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude